当前位置: X-MOL 学术Nat. Genet. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Targeting LSD1 and FOXA1 in prostate cancer
Nature Genetics ( IF 30.8 ) Pub Date : 2020-09-30 , DOI: 10.1038/s41588-020-0702-6
Soleilmane Omarjee , Jason S. Carroll

FOXA1 is a key pioneer factor in androgen-receptor activity but has been an elusive drug target. A new study shows that inhibition of the associated cofactor LSD1 modifies the methylation state of FOXA1, thus resulting in chromatin dissociation and tumor inhibition, even in models of treatment-resistant prostate cancer.

中文翻译:

针对前列腺癌中的LSD1和FOXA1

FOXA1是雄激素受体活性的关键先驱因子,但一直是难以捉摸的药物靶标。一项新研究表明,对相关辅因子LSD1的抑制作用会修饰FOXA1的甲基化状态,从而导致染色质解离和肿瘤抑制作用,即使在具有抗药性的前列腺癌模型中也是如此。
更新日期:2020-09-30
down
wechat
bug